This year alone, the United States
government has spent over $100m on the treatment of Neglected Tropical
Diseases in Nigeria, the Director of USAID Mission in Nigeria, Michael
Harvey, has said.
According to him, $6bn which was
sourced from over 40 organisations has been spent on medications for the
treatment of some diseases around the world, including Nigeria.
Among the diseases on which the $100m
was spent are malaria, elephantiasis (a parasitic infection spread by
some mosquitoes), river blindness (due to bites from infected black fly)
and helminthiasis (caused by certain tiny worms).
Others are bilharzia, also caused by tiny worms found in dirty and stagnant water; as well as trachoma, a blinding disease.
He said that the fight against the
different diseases in Nigeria has so far achieved over 60 per cent
success, alongside other innovative methods which have been initiated to
fight the NTDs such as preventive medicines.
“The US government has committed $100m
to fighting diseases in Nigeria in 2016 and so far, about 40
organisations, businesses and partners all over the world have
committed over $6bn on medications across the world,” Harvey stated.
The CEO/President of the Carter Centre,
Ambassador Mary Ann Peters, in her speech, said Nigeria was selected
out of the 14 countries because of its populous size in Africa and the
fact that it is most affected by all the diseases.
“Nigeria is the most affected of all
the NTDs, hence the choice of Carter Centre. In stemming the tide of the
diseases, 42 per cent of drugs and medications has been distributed in
Nigeria and the treatments were delivered in about 20,000 villages,” she
stated.
Our correspondent reports that the
Carter Centre championed the eradication of guinea worm in Nigeria
towards the free certification from the diseases in 2013.
The organisation has pledged to
continue its support towards the eradication of the NTDs and for which
eight states have so far benefitted.
US spends $100m on treatment of malaria, others in Nigeri
Reviewed by Unknown
on
Friday, November 04, 2016
Rating: 5
No comments: